Manu Jaggi
26Patents
7h-index
49Co-inventors
69Inventor score
Filing activity: Oct 8, 1996 → Mar 27, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6048847A | Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this | Chemistry; Metallurgy | 28 | Expired |
| US5744363A | Method for establishing a tumor-cell line by preparing single-cell suspension of tumor cells from tumor biopsies | Human Necessities | 13 | Expired |
| US6632832B1 | Anti-cancer activity of carvedilol and its isomers | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6403816B1 | Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis | Chemistry; Metallurgy | 12 | Expired |
| US6395771B1 | Paclitaxel derivatives for the treatment of cancer | Human Necessities | 10 | Expired |
| US6670345B1 | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid | Chemistry; Metallurgy | 10 | Expired |
| US6613793B2 | Anticancer activity of imino acid conjugates or methylglyoxal | Human Necessities | 9 | Expired |
| US6156725A | Drug for the treatment of cancer | Human Necessities | 6 | Expired |
| US6228850A | Antiangiogenic activity of betulinic acid and its derivatives | Chemistry; Metallurgy | 5 | Expired |
| US6828304B1 | Peptides for treatment of cancer | Human Necessities | 5 | Expired |
| US6492330B1 | Antiangiogenic drugs | Human Necessities | 5 | Expired |
| US7060678B2 | Peptides comprising furanoid sugar amino acids for the treatment of cancer | Human Necessities | 4 | Expired |
| US6316414A | Somatostatin analogs for the treatment of cancer | Human Necessities | 4 | Expired |
| US6214814A | Use of betulinic acid derivatives for inhibiting cancer growth | Chemistry; Metallurgy | 3 | Expired |
| US7173006B2 | Drug comprising synthetic peptide analogs for the treatment of cancer | Human Necessities | 2 | Expired |
| US6596692B1 | Substance P analogs for the treatment of cancer | Human Necessities | 2 | Expired |
| US8927023B2 | Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions | Chemistry; Metallurgy | 1 | Active |
| US6989371B1 | Bombesin analogs for treatment of cancer | Human Necessities | 0 | Expired |
| US6949513B2 | Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer | Chemistry; Metallurgy | 0 | Expired |
| US7781398B2 | Drug comprising synthetic peptide analogs for the treatment of cancer | Human Necessities | 0 | Active |
| US7179937B2 | Cyclopentenone derivatives for cancer therapy | Chemistry; Metallurgy | 0 | Expired |
| US8022055B2 | Betulinic acid derivatives | Chemistry; Metallurgy | 0 | Active |
| US6949557B2 | Hydroanthracene based compounds as anticancer agents | Chemistry; Metallurgy | 0 | Expired |
| US11344598B2 | Herbal nanoformulations for treating psoriasis and other skin conditions | Human Necessities | 0 | Active |
| US8338562B2 | Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.